Editorial: The multifaceted role of cholangiocytes in neoplastic and non-neoplastic cholangiopathies: from bench to bedside - Report - MDSpire

Editorial: The multifaceted role of cholangiocytes in neoplastic and non-neoplastic cholangiopathies: from bench to bedside

  • By

  • Alessandro Gambella

  • Michele Pinon

  • July 15, 2026

Share

Clinical Report: Exploring the Diverse Functions of Cholangiocytes in Cholangiopathies

Overview

This editorial discusses the roles of cholangiocytes in neoplastic and non-neoplastic cholangiopathies, focusing on their functions in health and disease.

Background

Cholangiocytes, the epithelial cells lining the bile ducts, play roles in maintaining biliary homeostasis and responding to injury. Their plasticity can lead to maladaptive responses in disease states, contributing to chronic inflammation and fibrosis.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Cholangiocytes are involved in bile secretion, epithelial repair, and immune signaling.
  • Maladaptive cholangiocyte responses can lead to chronic biliary injury and carcinogenesis.
  • Genetic and developmental cholangiopathies demonstrate the impact of altered biliary development on cholestatic phenotypes.
  • A prognostic nomogram for primary biliary cholangitis (PBC) was developed, integrating clinical factors for survival prediction.
  • Diagnostic complexities in immune-mediated pancreatobiliary disease require careful follow-up beyond initial cholestasis resolution.

Clinical Implications

Clinicians should consider the roles of cholangiocytes when evaluating cholangiopathies.

Conclusion

The editorial discusses the roles of cholangiocytes in health and disease.

Related Resources & Content

  1. Liu et al., Journal of Gastroenterology, Year -- Prognostic nomogram for PBC
  2. Guglielmo et al., Frontiers in Immunology, Year -- Immune-mediated pancreatobiliary disease
  3. Yang et al., Journal of Gastroenterology, Year -- IgG4-related sclerosing cholangitis
  4. Bock et al., Journal of Gastroenterology, Year -- Biliary stents for malignant obstruction
  5. Frontiers in Immunology — Unraveling immunological heterogeneity in recalcitrant AIH-PBC/PSC overlap syndromes: from molecular crosstalk to precision therapeutics
  6. EASL Clinical Practice Guidelines on extrahepatic cholangiocarcinoma
  7. AASLD Primary Sclerosing Cholangitis Management Tips and Tricks
  8. Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer: A Post Hoc Analysis of the TOPAZ-1 Randomized Clinical Trial | Targeted and Immune Therapy | JAMA Oncology | JAMA Network

Original Source(s)

Related Content